Financhill
Sell
28

AKRO Quote, Financials, Valuation and Earnings

Last price:
$28.26
Seasonality move :
-9.11%
Day range:
$27.51 - $28.99
52-week range:
$15.32 - $37.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
2.67x
Volume:
451.4K
Avg. volume:
637.3K
1-year change:
16.49%
Market cap:
$2B
Revenue:
--
EPS (TTM):
-$3.78

Earnings Data

Next earnings date for AKRO
Feb 28
2025
Most recent earnings per share
-$1.05
Missed by $0.12
(Nov 8/2024)
Consensus Estimate
-$0.93
(Nov 8/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

AKRO Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/28/2025 Q4 -- -- -- -$1.13 --
11/08/2024 Q3 -- -- -$1.05 -$0.93 -$0.12
08/09/2024 Q2 -- -- -$0.81 -$0.89 $0.08
05/10/2024 Q1 -- -- -$0.90 -$0.93 $0.03
02/29/2024 Q4 -- -- -$1.02 -$0.83 -$0.19
11/13/2023 Q3 -- -- -$0.71 -$0.69 -$0.02
08/11/2023 Q2 -- -- -$0.60 -$0.71 $0.11
05/15/2023 Q1 -- -- -$0.55 -$0.64 $0.09
03/17/2023 Q4 -- -- -$0.49 -$0.83 $0.34
11/04/2022 Q3 -- -- -$0.92 -$0.73 -$0.19
08/05/2022 Q2 -- -- -$0.77 -$0.86 $0.09
05/06/2022 Q1 -- -- -$0.74 -$0.84 $0.10
02/25/2022 Q4 -- -- -$0.93 -$0.81 -$0.12
11/12/2021 Q3 -- -- -$0.70 -$0.91 $0.21
08/13/2021 Q2 -- -- -$0.83 -$0.71 -$0.12
05/13/2021 Q1 -- -- -$0.43 -$0.94 $0.51
03/16/2021 Q4 -- -- -$0.86 -$0.60 -$0.26
11/12/2020 Q3 -- -- -$0.63 -$0.67 $0.04
08/12/2020 Q2 -- -- -$0.57 -$0.62 $0.05
05/13/2020 Q1 -- -- -$0.42 -$0.61 $0.19
03/16/2020 Q4 -- -- -$0.55 -$0.58 $0.03
11/12/2019 Q3 -- -- -$0.56 -$0.43 -$0.13
08/12/2019 Q2 -- -- -$0.26 -$0.36 $0.10

Akero Therapeutics Earnings Questions

  • How Much did Akero Therapeutics Generate in Revenue Last Quarter?

    Akero Therapeutics reported -- worth of top line sales in its most recent quarter.

  • Did Akero Therapeutics Beat Earnings Last Quarter?

    Akero Therapeutics announced earnings per share of -$1.05 which represents a miss of analyst forecast a -$0.93 per share.

  • Is Akero Therapeutics Profitable?

    Akero Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Akero Therapeutics EPS Next Year?

    Akero Therapeutics's earnings are forecast to decrease from -$2.89 per share to -$2.89 per share next year representing a decrease of -37.38%.

  • When is Akero Therapeutics's Earnings Date?

    Akero Therapeutics's next earnings date is February 28, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Uber Stock a Buy on the Dip?
Is Uber Stock a Buy on the Dip?

Shares of Uber Technologies (NYSE:UBER) have been fading fast in…

Is AMD Stock an All-Time Buy?
Is AMD Stock an All-Time Buy?

Advanced Micro Devices (NASDAQ:AMD) is a high-growth AI stock that…

How High Will Airbnb Stock Go?
How High Will Airbnb Stock Go?

Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 117x

Buy
54
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Alerts

Sell
50
LMND alert for Dec 28

Lemonade [LMND] is down 10.69% over the past day.

Buy
60
TSLL alert for Dec 28

Direxion Daily TSLA Bull 2X Shares [TSLL] is down 9.92% over the past day.

Buy
71
SMLR alert for Dec 28

Semler Scientific [SMLR] is down 9.65% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock